I like that some centres will be in the USA.
Maybe the USA patients will show significant improvement in PMD and the rest of the world patients won't and all regulators will be happy.
- Forums
- ASX - By Stock
- Ann: Global Phase 3 Trial of Presendin to Launch in Q4 2021
IXC
invex therapeutics ltd
Add to My Watchlist
8.24%
!
9.2¢

I like that some centres will be in the USA. Maybe the USA...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
9.2¢ |
Change
0.007(8.24%) |
Mkt cap ! $6.914M |
Open | High | Low | Value | Volume |
9.2¢ | 9.2¢ | 9.2¢ | $8 | 87 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5434 | 8.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.5¢ | 99600 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5434 | 0.087 |
1 | 100000 | 0.085 |
1 | 100000 | 0.084 |
1 | 100000 | 0.083 |
1 | 40000 | 0.075 |
Price($) | Vol. | No. |
---|---|---|
0.095 | 99600 | 1 |
0.096 | 37163 | 1 |
0.097 | 8998 | 1 |
0.099 | 21180 | 1 |
0.100 | 136140 | 1 |
Last trade - 10.28am 01/08/2025 (20 minute delay) ? |
Featured News
IXC (ASX) Chart |
The Watchlist
RC1
REDCASTLE RESOURCES LIMITED
Ron Miller, Non-Executive Director
Ron Miller
Non-Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online